FDA warns J&J unit and Sientra over breast implant compliance - 0 views
-
jacob logan on 21 Mar 19The US Food and Drug Administration (FDA) has sent warning letters to a Johnson & Johnson unit, Mentor Worldwide, and Sientra for failure to comply with its post-approval study requirements for breast implants.